

| Revenue | $1 - $10 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Address | 400 Trade Center Suite 6990 Woburn, MA 01801 |
| Axial Biotherapeutics | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $1 - $10 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Axial Biotherapeutics P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| NMM Medical information; providing medical information; providing medical information from a web site; Providing medical information in the fields of pharmaceuticals, nutrition supplements, and probiotic supplements | 06/07/2022 |
| AXIAL THERAPEUTICS Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids | 10/03/2019 |
| AXIAL BIOTHERAPEUTICS Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut | 04/26/2017 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| SYSTEMS & TECHNOLOGY RESEARCH | Woburn, MA | 100 |
| TRANSMEDICS | Andover, MA | 44 |
| 6K | North Andover, MA | 35 |
| PHYSICAL SCIENCES | Andover, MA | 33 |
| TRITON SYSTEMS | Chelmsford, MA | 30 |
| COVARIS | Woburn, MA | 29 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| VERDE FARMS | Woburn, MA | 100 |
| HEALTHCARESOURCE HR | Woburn, MA | 45 |
| BIOSS | Woburn, MA | 19 |
| SNOWCAP TECHNOLOGIES | Woburn, MA | 5 |
| AMA XPERTEYE | Woburn, MA | 1 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |